Journal of Food Hygiene and Safety (한국식품위생안전성학회지)

The Korean Society of Food Hygiene and Safety (한국식품위생안전성학회)
권호 표지

Stem Cells and Cell-Cell Communication in the Understanding of the Role of Diet and Nutrients in Human Diseases

  • Trosko James E. (Center for Integrative Toxicology, National Food Safety Toxicology Center, Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University)
  • Published : 2007.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

The term, "food safety", has traditionally been viewed as a practical science aimed at assuring the prevention acute illnesses caused by biological microorganisms, and only to a minor extent, chronic diseases cause by chronic low level exposures to natural and synthetic chemicals or pollutants. "food safety" meant to prevent microbiological agents/toxins in/on foods, due to contamination any where from "farm to Fork", from causing acute health effects, especially to the young, immune-compromised, genetically-predisposed and elderly. However, today a broader view must also include the fact that diet, perse (nutrients, vitamins/minerals, calories), as well as low level toxins and pollutant or supplemented synthetic chemicals, can alter gene expressions of stem/progenitor/terminally-differentiated cells, leading to chronic inflammation and other mal-functions that could lead to diseases such as cancer, diabetes, atherogenesis and possibly reproductive and neurological disorders. Understanding of the mechanisms by which natural or synthetic chemical toxins/toxicants, in/on food, interact with the pathogenesis of acute and chronic diseases, should lead to a "systems" approach to "food safety". Clearly, the interactions of diet/food with the genetic background, gender, and developmental state of the individual, together with (a) interactions of other endogenous/exogenous chemicals/drugs; (b) the specific biology of the cells being affected; (c) the mechanisms by which the presence or absence of toxins/toxicants and nutrients work to cause toxicities; and (d) how those mechanisms affect the pathogenesis of acute and/or chronic diseases, must be integrated into a "system" approach. Mechanisms of how toxins/toxicants cause cellular toxicities, such as mutagenesis; cytotoxicity and altered gene expression, must take into account (a) irreversible or reversal changes caused by these toxins or toxicants; (b)concepts of thresholds or no-thresholds of action; and (c) concepts of differential effects on stem cells, progenitor cells and terminally differentiated cells in different organs. This brief Commentary tries to illustrate this complex interaction between what is on/in foods with one disease, namely cancer. Since the understanding of cancer, while still incomplete, can shed light on the multiple ways that toxins/toxicants, as well as dietary modulation of nutrients/vitamins/metals/ calories, can either enhance or reduce the risk to cancer. In particular, diets that alter the embryo-fetal micro-environment might dramatically alter disease formation later in life. In effect "food safety" can not be assessed without understanding how food could be 'toxic', or how that mechanism of toxicity interacts with the pathogenesis of any disease.

Keywords

References

  1. Potter, V.R. The role of nutrition in cancer prevention. Science 101, 105-109 (1945) https://doi.org/10.1126/science.101.2614.105
  2. Goodman, G.E., Thornquist, M.D., Balmes, J., Cullen, M.R., Meysken, F.L., Omenn, G.S., Valanis, G.S., Wiulliam, J.H. The beta-carotene and retinol efficacy trial: Incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping betacarotene and retinol supplements. J. Natl Cancer Instit., 96, 1743-1750 (2004) https://doi.org/10.1093/jnci/djh320
  3. Trosko, J.E., Chang, C.C., Upham, B., and Wilson, M. Epigenetic toxicology as toxicant-induced changes in intracellular signaling leading to altered gap junctional intercellular communication. Toxicol. Letters, 102-103, 71-78 (1998) https://doi.org/10.1016/S0378-4274(98)00288-4
  4. Milton, K. Back to basics: Why foods of wild primates have relevance for modern human health. Nutrition, 16, 480-483 (2000) https://doi.org/10.1016/S0899-9007(00)00293-8
  5. Kiple, K.F. (ed.) The Cambridge World History of Food. Cambridge University Press, (2000)
  6. Teaford, M.F. and Ungar, P.S. Diet and the evolution of the earliest human ancestors. Proc. Natl. Acad. Sci. USA 97, 13506-13511 (2000)
  7. Mariani-Costantini, A. Natural and cultural influences on the evolution of the human diet: Backgroung of the multifactorial processes that shaped the eating habits of Western societies. Nutrition 16, 483-486, (2000) https://doi.org/10.1016/S0899-9007(00)00296-3
  8. Cordain, L., Miller, J.B., Eaton, S.B., Mann, N., Holt, S.H.A., and Speth, J.D. Plant-animal subsistence ratios and micronutrient energy estimates in worldwide huntergather diets. Am. J. Clin. Nutr., 71, 682-692 (2000) https://doi.org/10.1093/ajcn/71.3.682
  9. Paoloni-Giacobino, Grimble, R., and Pichard, C. Genetics and nutrition. Clin. Nutr., 22, 429-435 (2003) https://doi.org/10.1016/S0261-5614(03)00064-5
  10. Calle, E.E., and Kaaks, R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nature Reviews/Cancer 4, 579-591 (2004) https://doi.org/10.1038/nrc1408
  11. Calle, E.E. and Kaaks, R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nature Reviews/Cancer, 4, 579-591 (2004) https://doi.org/10.1038/nrc1408
  12. Trosko, J.E., and Chang, C.C. Nongenotoxic mechanism in carcinogenesis: Role of inhibited intercellular communication. In: Banbury Report 31: Carcinogen Risk Assessment: New Directions in the Qualitative and Quantitative Aspects. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 139-170, (1988)
  13. Horvath, A., Upham, B.L., Ganev, V., and Trosko, J.E. Determination of the epigenetic effects of ochratoxin in a human kidney and a rat liver epithelial cell line. Toxicon 40, 273-282, (2002) https://doi.org/10.1016/S0041-0101(01)00219-7
  14. Hilliard, C.A., Armstrong, M.J., Bradt, C.I., Hill, R.B., Green, S.K., Greenwood, X.X., and Galloway, S.M. Chromosome aberration in vitro related to cytotoxicity of nonmutagenic chemicals and metabolic poisons. Environ. Molec. Mutagen., 31, 316-326 (1988) https://doi.org/10.1002/(SICI)1098-2280(1998)31:4<316::AID-EM3>3.0.CO;2-G
  15. Trosko, J.E., and Upham, B.L. 'Carcinogen as Mutagen' As a Destructive Paradigm: Chemical Carcinogenes are not mutagens', Mutation Research, in press
  16. Trosko, J.E., and Upham, B.L. 'The emperor wears no clothes in the field of carcinogen risk assessment: Ignored concepts in cancer risk assessment'. Mutagenesis 20, 81-92 (2005) https://doi.org/10.1093/mutage/gei017
  17. Benditt, E.P., and Benditt, J.M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. USA, 70, 1733-1736 (1973)
  18. Pitot, H.C., and Dragon, Y.P. Facts and theories concerning the mechanisms of carcinogenesis. FASEB J., 5, 2280-2286 (1991) https://doi.org/10.1096/fasebj.5.9.1860619
  19. Trosko, J.E. From adult stem cells to cancer stem cells: Oct-4 gene, Cell-cell communication and hormones during tumor promotion. Ann. N.Y. Acad. Sci., 1089, 36-58 (2006) https://doi.org/10.1196/annals.1386.018
  20. Trosko, J.E., and Tai, M.H. Adult stem cell theory of the multistage, multi- mechanism theory of carcinogenesis: role of inflammation on the promotion of initiated stem cells. In: Infection and Inflammation: Impacts on Oncogenesis. Dittmar, T, ed., Karger AG, Amsterdam, 45-65 (2006)
  21. Bursch, F., Oberhammer, F., and Schulte-Hermann, R. Cell death by apoptosis and its protective role against disease. Trends Pharmacol. Sci., 13, 245-251 (1992) https://doi.org/10.1016/0165-6147(92)90077-J
  22. Wilson, M.R., Close, T.W., and Trosko, J.E. Cell Population dynamics( apoptosis, mitosis and cell-cell communication) during disruption of homeostasis. Exp. Cell res., 254, 257-268 (2000) https://doi.org/10.1006/excr.1999.4771
  23. Slaga, T.J., Fischer, S.M., Weeks, C.E., Nelson, K., Mamrack, M., and Klein-Szanto, A.J.P. Specificity and mechanisms of promoter inhibitors in multistage promotion. In: Carcinogenesis, Vol 7, Hecker, E, Fusenig NE, Kunz W, Marks F, and Theilmann HW, eds., Raven Press, N.Y., N.Y., 19-34 (1982)
  24. Trosko, J.E., Chang, C.C., Madhukar, B.V., Dupont, E. Intercellular communication: A paradigm for the interpretation of the initiation/promotion model of carcinogenesis. In: Chemical Induction of Cancer: Modulation and Combination Effects. Arcos, JC, ed. Birkhauser Press, Boston, 205-225, (1996)
  25. Land, H., Parada, L.F., and Weinberg, R.A. Tumorigenic conversion of primary embryo fibroblast requires at least two cooperating oncogenes. Nature 304, 596-602 (1983) https://doi.org/10.1038/304596a0
  26. Trosko, J.E. and Ruch, R.J. Cell-cell communication in carcinogenesis. Front. Biosci., 3, 208-236 (1998) https://doi.org/10.2741/A275
  27. Tai, M.H., Chang, C.C., Kiupel, M., Webster, J., and Trosko, J.E. Oct-4 expression in adult stem cells: Evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 26, 495-502 (2005) https://doi.org/10.1093/carcin/bgh321
  28. Brash, D.E., Rudolph, J.A, Simon, A., Lin, A., McKenna, G.J., et al. A role for sunlight in skin cancer: UVinduced p53 mutations in squamous cell carcinomas. Proc. Natl. Acad. Sci. USA, 88, 10124-1018 (1991)
  29. Trosko, J.E., and Ruch, R.J. Gap junctions as therapeutic targets, Current Drug Targets, 3, 465-482 (2002) https://doi.org/10.2174/1389450023347371
  30. Goodman, J.A. Operational reversibility is a key aspect of carcinogenesis. Toxicol. Sci., 64, 147-148 (2001) https://doi.org/10.1093/toxsci/64.2.147
  31. Trosko, J.E., and Ruch, R.J. Gap junctional Intercellular Communication in Epigenetic Toxicology. In: Encyclopedia of Toxicology, 2nd Ed., Wexler P, ed., Elsevier Press, Oxford, 402- 407, (2005)
  32. Tumbar, T., Guasch, G., Greco, V., Blanpain, C., Lowry, W.E., Rendl, M., and Fuchs, E. Defining the epithelial stem cell niche in skin. Science 303, 359-363 (2004) https://doi.org/10.1126/science.1092436
  33. Trosko, J.E., Chang, C.C., Wilson, M.R., Hayashi, H., and Wade, M. Gap junctions and the regulation of cellular functions of stem cells during development and differentiation. Methods 20, 245-264 (2000) https://doi.org/10.1006/meth.1999.0941
  34. Cruciani, V., and Mikalsen, S.-O. The connexin gene family in mammals. Biol Chem., 386, 325-332 (2005) https://doi.org/10.1515/BC.2005.039
  35. Yamasaki, H., and Naus, C.C.G. Role of connexin genes in growth control. Carcinogenesis 17, 1199-1213 (1996) https://doi.org/10.1093/carcin/17.6.1199
  36. Evans, W.H., and Martin, P.E.M. Gap junctions: Structure and Function. Molec. Membr. Biol., 19, 121-136 (2002) https://doi.org/10.1080/09687680210139839
  37. Revel, J.P. The oldest multicellular animal and its junctions. In: Gap Junctions. Hertzberg, E.L., and Johnson, R. eds., Alan Liss, Inc., N.Y., 135-149 (1988)
  38. Herve, J.-C., Bourmeyster, N., and Sarrouilhe, D. Diversity in protein-protein interactions of connexins: emerging roles. Biochim. Biophys. Acta 1662, 22-41 (2004) https://doi.org/10.1016/j.bbamem.2003.10.022
  39. Cornish-Bowden, A. Putting the systems back into systems biology. Perspect. Biol. Med., 49, 475-489 (2006) https://doi.org/10.1353/pbm.2006.0053
  40. Roscoe, W., Veitch, G.I.L., Gong, X.-Q., Pelligrino, E., Bai, D., McLachlan, E., Shao, Q., Kidder, G.M., and Laird, D. Oculodentodigital dysplasia-causing connexin43 mutants are non-functional and exhibit dominant effects on wild type connexin43. J. Biol. Chem., 280, 11458-11466 (2005) https://doi.org/10.1074/jbc.M409564200
  41. Abrams, C.K., and Bennett, M.V.L. Hereditary human diseases caused bu connexin mutations. Current Topics Membranes 49, 423-459 (2000)
  42. Theis, M., Magin, T.M., Plum, A., and Willecke, K. General or cell type specific deletion and replacement of connexin-coding DNA in the mouse. Methods 20, 205- 218 (2000) https://doi.org/10.1006/meth.1999.0938
  43. Trosko, J.E., Chang, C.C., and Upham, B.L. Modulation of gap junctional communication by epigenetic toxicants: A shared mechanism in teratogenesis, carcinogenesis, atherogenesis, immunomodulation, reproductiveand neuron-toxicities. In: Biomarkers of EnvironmentallyAssociated Diseases. Wilson, S.H. and Suk, W.A., eds., Lewis Press, Boca Raton, Fl., 445-454, (2002)
  44. Loewenstein, W.R. Permeability of membrane junctions. Ann. N.Y. Acad. Sci., 137, 441-472 (1966) https://doi.org/10.1111/j.1749-6632.1966.tb50175.x
  45. Yotti LP, Chang CC, and Trosko JE: Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter. Science 206, 1089-1091 (1979) https://doi.org/10.1126/science.493994
  46. Trosko JE: Is the concept of 'tumor promotion' a useful paradigm? Molec. Carcinogen., 30, 131-137 (2001) https://doi.org/10.1002/mc.1021
  47. Houghton, F.D. Role of gap junctions during early embryo development. Reproduction 129, 129-135 (2005) https://doi.org/10.1530/rep.1.00277
  48. Lo, C.W. The role of gap junction membrane channels in development. J. Bioenerg. Biomembr., 28, 379-385 (1996) https://doi.org/10.1007/BF02110114
  49. Trosko, J.E. The role of stem cells and gap junctional communication in carcinogenesis. J. Biochem. Molec. Biol., 36, 43-48 (2003) https://doi.org/10.5483/BMBRep.2003.36.1.043
  50. King, T.J., Fukushima, L.H., Donlon, T.A., Hieber, A.D., Shimabukuro, K.A. and Bertram, J.S. Correlation between growth control, neoplastic potential and exogenous connexin43 expression in HeLa cell lines: Implications for tumor progression. Carcinogenesis 21, 311- 315 (2000) https://doi.org/10.1093/carcin/21.2.311
  51. Momiyama, M., Omori, Y., Ishizaka, Y., Nishikawa, Y., Tokairin, T., Ogawa, J. and Enomoto, K. Connexin26- mediated gap junctional communication reverses the the malignant phenotypic of MCF-7 breast cancer cells. Cancer Sci., 94, 501-507 (2003) https://doi.org/10.1111/j.1349-7006.2003.tb01473.x
  52. Trosko, J.E. Gap junctional intercellular as a biological 'Rosetta Stone' in understanding in a systems biological manner, stem cell behavior, mechanisms of epigenetic toxicology, chemoprevention and chemotherapy. In Press. XXXXX
  53. Fritz, W.A., Coward, L., Wang, J., and Lamartiniere, C.A. Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in rats. Carcinogenesis 19, 2151-2158 (1998) https://doi.org/10.1093/carcin/19.12.2151
  54. Hsieh, C.Y. and Chang, C.C. Stem cell differentiation and reduction as a potential mechanism for chemoprevention of breast cancer. Chinese Pharmaceutical J., 51, 15-30 (1999) https://doi.org/10.1211/0022357991772033
  55. Thompson, D.E., Mabuchi, K., Ron, E., Soda, M., Tokunaga, M., Ochikubo, S., Sugimoto, S., Ikeda, T., Terasaki, M., Preston, D.L. Cancer incidence in abomic bomb survivors. Part II: Solid tumors 1958-1987. Radiat. Res. 137, S17-S67 (1994) https://doi.org/10.2307/3578892
  56. Fang, M.Z., Chen, D., Sun, Y., Christman, J.K., and Yang, C.S. Reversal of hypermethylation and reactivation of p16ink4a, RARb, and MGMT genes by genistein and isoflavones from soy. Clin. Cancer Res., 11, 7033- 7041 (2005) https://doi.org/10.1158/1078-0432.CCR-05-0406
  57. Kennedy, A.R. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent. Am. J. Clin. Nutr. 68, 1406S-1412S (1998) https://doi.org/10.1093/ajcn/68.6.1406S
  58. Hen, Y.W., Huang, S.C., Lin-Shiau, S.Y., and Lin, J.K. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF-7 breast cancer cells through accumulation of MAP kinase phosphatase-1. Carcinogenesis 26, 1296-1306 (2005) https://doi.org/10.1093/carcin/bgi062
  59. Messina, M.J., Persky, V., Setchell, K.D., and Barnes, S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer 21, 113-131 (1994) https://doi.org/10.1080/01635589409514310
  60. Trosko, J.E., Madhukar, B.V., and Chang, C.C. Endogenous and exogenous modulation of gap junctional intercellular communication: Toxicological and pharmacological implications. Life Sciences 53, 1-19 (1993) https://doi.org/10.1016/0024-3205(93)90606-4
  61. Chang, C.C. Recent translational research: stem cells as the roots of breast cancer. Breast Cancer Research 8, 103-105 (2006) https://doi.org/10.1186/bcr1385
  62. Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kaira, A., Prabhu, V.V., Allard, J.S., et al. Resveratrol improves health and survival of mice on a highcaloric diet. Nature 444, 337-342 (2006) https://doi.org/10.1038/nature05354
  63. Nielson, M., Ruch, R.J., and Vang, O. Resveratrol reverses tumor-promoter-induced inhibition of gap junctional intercellular communication. Biochem. Biophys. Res. Commun., 275, 804-809 (2000) https://doi.org/10.1006/bbrc.2000.3378
  64. Chen, T.H., Kavanagh, T., Chang, C.C. and Trosko, J.E. Inhibition of metabolic cooperation in Chinese hamster V79 cells by various organic solvents and simple compounds. Cell Biol. Toxicol. 1, 155-171 (1984) https://doi.org/10.1007/BF00125572
  65. Umemura, T., Kai, S., Hasegawa, R., Sai, K., Kurokawa, Y., and Williams, G.M. Pentachlorophenol (PCP) produces liver oxidative stress and promotes but does not initiate hepatocarcinogenesis in B6C3F1 mice. Carcinogenesis 6, 1115-1120 (1999)
  66. Sai, K., Kanno, J., Hasegawa, R., Trosko, J.E., and Inoue, T. Prevention of the down regulation of gap junctional intercellular communication by green tea in the liver of mice fed pentachlorophenol. Carcinogenesis 21, 1671-1676 (2000) https://doi.org/10.1093/carcin/21.9.1671
  67. Hanahan, D. and Weinberg, R.A. The hallmarks of cancer. Cell 100, 57-70 (2000) https://doi.org/10.1016/S0092-8674(00)81683-9
  68. Roberfroid, M.B. Global view on functional foods: European perspectives. Br. J. Nutr., 88, S133-S138 (2002) https://doi.org/10.1079/BJN2002677
  69. Shuin, T., Nishimura, R., Noda, K., Umeda, M. and Ono, T. Concentration-dependent differential effect of retinoic acid on intercellular metabolic cooperation. Gann 74, 100-105 (1983)
  70. Forbes, P.D., Urbach, F., and Davies, R.E. Enhancement of experimental photocarcinogenesis by topical retinoic acid. Cancer Letters 7, 85-90 (1979) https://doi.org/10.1016/S0304-3835(79)80100-7
  71. Welsch, C.W., Goodrich-Smith, M., Brown, C.K., and Crowe, N. Enhance by retinyl Acetate of hormoneinduced mammary tumorigenesis in female GR/A mice. J. Natl. Cancer Instit., 67, 935-938 (1981)
  72. Henning, H., Wenk, M.L., and Donahoe, R. retinoic acid promotion of papilloma formation in mouse skin. Cancer Letters 16, 1-5 (1982) https://doi.org/10.1016/0304-3835(82)90084-2
  73. Fischer, S.M., Klein-Szanto, J.P., Adams, L.M., and Slaga, T.J. The first stage and complete promoting activity of retinoic acid, but not the analog RO-10-9359. Carcinogenesis 6, 575-578 (1985) https://doi.org/10.1093/carcin/6.4.575
  74. Cerruti, P.A. Prooxidant states and tumor promotion. Science 227, 375-381 (1985) https://doi.org/10.1126/science.2981433
  75. Smalley, K.S.M., Lioni, M, and Herlyn, M. Life isn't flat: Cancer biology to the next dimension. In Vitro Biol.- Animal 42, 242-247 (2006) https://doi.org/10.1290/0604027.1
  76. Hirose, M., Yada, H., Hakoi, K., Takahashi, S., and Ito, N. Modification of carcinogenesis by alpha- tocopherol, t-butylhydroquinone, propyl gallate and butylated hydrotoluene in a rat multi-organ carcinogenesis model. Carcinogenesis 14, 2359-2364 (1993) https://doi.org/10.1093/carcin/14.11.2359
  77. Ito, N., Hirose, M., Shibata, M.A., Tanaka, H., and Shirai, T. Modifying effects of simultaneous treatment with butylated hydroxyanisole (BHA) on rat tumor induction by 3,2'-dimethyl-4-aminobiphenyl, 2,2'-dihydroxy-di-npropylnitrosamine and N-methylnitrosourea. Carcinogenesis 10, 2255-2259 (1989) https://doi.org/10.1093/carcin/10.12.2255
  78. Goodman, J., Trosko, J.E. and Yager, J.D. Studies on the mechanism of inhibition of 1-acetylaminofluorene toxicity by butylated hydroxytoluene. Chem.-Biol. Interact. 12, 171-182 (1976) https://doi.org/10.1016/0009-2797(76)90097-1
  79. Cohen, G.M., Bracken, W.H., Iyer, R.P., Berry, D.L., Selkirk, J.K., and Slaga, T.J. Anticarcinogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on benzo(a) pyrene and 7,12-dimethylbenz(a) anthracene tumor initiation and its relationship to DNA binding. Cancer Res., 39, 4027-4033 (1979)
  80. Kushida, M., Sukata, T., Uwagawa, S., Ozaki, K., Kinoshita, A., Wanibuchi, H., Morimura, K., Okuno, Y., and Fukushima, S. Low dose DDT inhibition of hepatocarcinogenesis by dietrhyulnitrosamine in male rats: Possible mechanisms. Toxicol. Appl. Pharmacol., 208, 285-294 (2005) https://doi.org/10.1016/j.taap.2005.03.018
  81. Lee, G.-H. Paradoxical effects of phenobarbital on mouse hepatocarcinogenesis. Toxicol. Path., 28, 215-225 (2000) https://doi.org/10.1177/019262330002800201
  82. Klaunig, J. and Ruch, R.J. Strain and species effects on the inhibition of hepatocyte intercellular communication by liver tumor promoters. Cancer Letters 36, 161-168, (1987) https://doi.org/10.1016/0304-3835(87)90087-5
  83. Lamartiniere, C.A., Moore, J.B., Brown, N.M., Thompson, R., Hardin, M.J., and Barnes, S. Genistein suppresses mammary cancers in rats. Carcinogenesis 16, 2833-2840 (1995) https://doi.org/10.1093/carcin/16.11.2833
  84. Ju, Y.H., Allred, C.D., Allred, K.F., Karko, K.L., Doerge, D.R., and Helferich, W.G. Physiological concentrations of dietary genisten dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J. Nutr., 131, 2957-2962 (2001) https://doi.org/10.1093/jn/131.11.2957
  85. Day, J.K., Besch-Williford, C., McMann, T.R., Hufford, M.G., Lubahn, D.B., and MacDonald, R.S. Dietary genestein increased DMBA-induced mammary adenocarcinoma in wild-type, but not ERalphaKO, mice. Nutr. Cancer 39, 226-232 (2001) https://doi.org/10.1207/S15327914nc392_11
  86. Kallistratos, G.I., Fasske, E.E., Donos, A.G. and Evangelou, A.M. Elucidation of the variable effect of vitamin C on experimental malignant tumors in Wistar rats. Chimika Chronika 13, 173-184 (1984)
  87. Birt, D.F., Pelling, J.C., Pour, P.M., Tibbets, M.G., Schweickert, L. and Bresnick, E. Enhanced pancreatic and skin tumorigenesis in cabbage-fed hamsters and mice. Carcinogenesis 8, 913-917 (1987) https://doi.org/10.1093/carcin/8.7.913
  88. Linkov, I., Wilson, R., and Gray, G.M. Weight and survival depression in rodent bioassays with and without tumor decreases. Toxicol. Sci., 43 (1988)
  89. Linkov, I., Wilson, R., and Gray, G.M. Anticarcinogenic responses in rodent cancer bioassays are not explained by random effects. Toxicol. Sci., 43, 1-9 (1998) https://doi.org/10.1093/toxsci/43.1.1
  90. Zeiger, E. Illusions of safety: antimutagens can be mutagens, and anticarcinogens can be carcinogens. Mutat. Res. 543, 191-194 (2003) https://doi.org/10.1016/S1383-5742(02)00111-4
  91. Couzin, J. Quirks of fetal environment felt decades later. Science 296, 2167-2169 (2002) https://doi.org/10.1126/science.296.5576.2167
  92. Travis, K. Eat your way to better DNA. The Scientist 20, 51-57 (2006)
  93. Dolinoy, D.C., Weidman, J.R., Waterland, R.A., and Jirtle, R.L. Maternal genistein alters coat color and protets Avy mouse offspring from obesity by modifying the fetal epigenome. Environ. Health Perspect., 114, 567-572 (2006) https://doi.org/10.1289/ehp.8700
  94. Ho, S.-M., Tang, W.Y., de Frauto, J.B., Prins, G.S. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase Type 4 Variant 4. Cancer Res., 66, 5624-5632 (2006) https://doi.org/10.1158/0008-5472.CAN-06-0516
  95. Hsieh, C.-Y., Chang, C.C. Stem cell differentiation and reduction sas a potential mechanism for chemoprevention of breast cancer. Chinese Pharm. J., 51, 15-30 (1999) https://doi.org/10.1211/0022357991772033
  96. Nakamura, Y., Yoshikawa, N., Hiroki, I., Sato, K., Ohtsuki, K., Chang, C.C., Upham, B.L., and. Trosko, J.E.. $\beta$- Sitosterol, From Psyllium Seed Husk (Plantago ovata Forsk), Restores Gap Junctional Intercellular Communication in Ha-ras Transfected Rat Liver Cells. Nutrition and Cancer, 5, 218-225 (2005)
  97. Guarente, L. Sirtuins as potential targets for metabolic syndrome. Nature 444, 868-874 (2006) https://doi.org/10.1038/nature05486
  98. Hotamisligil, G.S. Inflammationm and metabolic disorders. Nature 444, 860-866 (2006) https://doi.org/10.1038/nature05485
  99. Kaput, J. Diet-disease gene interactions. Nutrition 20, 26-31 (2004) https://doi.org/10.1016/j.nut.2003.09.005
  100. Kaput, J. and Rodriguez, R.L. Nutritional genomics: the next frontier in the postgenomic era. Physiol. Genomics 16, 166-177 (2004) https://doi.org/10.1152/physiolgenomics.00107.2003
  101. Yach, D., Leeder, S.R., Bell, J., and Kistnasamy, B. Global chronic disease. Science 307, 317 (2005) https://doi.org/10.1126/science.307.5708.317
  102. Danaei, G., Vander Hoorn, S., Lopez, A.D.S., Murray, C.J.L., Ezzati, M. Comparative Risk Assessment collaborating group: Causes of cancer in the world: comparative risk assessment of nine behavioral and environmental risk factors. Lancet 366, 1784-1793 (2005) https://doi.org/10.1016/S0140-6736(05)67725-2
  103. Roberfroid, M.B.: Global view on functional foods: European perspectives. Brit. J. Nutrit., 88, S133-S138 (2002) https://doi.org/10.1079/BJN2002677